Hypersensitivity reactions to fillers may occur after COVID-19 vaccination People may experience hypersensitivity reactions to fillers following a COVID-19 vaccination.
High rates of RSV in children over the summer, and a late flu epidemic in the 2021-2022 season Hospitals reported an unusually large number of children presenting with RSV over the summer of 2021. The number of positive coronavirus tests rapidly increased after the summer of 2021.
Satellite data on emissions may be even more precise and user-friendly Satellites are continuously improving and provide more precise measurements. They are used, for example, for studying emissions of greenhouse gases and other air pollutants.
Repeat vaccination against COVID-19: risk groups first, then everyone 12 and up The first invitations for a repeat vaccination against COVID-19 will be received by people in the Netherlands on 13 September 2022. RIVM will invite the oldest people first, and will then send an invitation to everyone aged 60 years and older.
Nearly one quarter of the Dutch population suffers from stomach, liver and/or bowel problems In 2019, nearly one in four people in the Netherlands had visited their general practitioner for stomach, liver and/or bowel problems of a more or less serious nature.
Use of Salvia divinorum may have adverse health effects The use of Salvia divinorum may have adverse health effects. Among other things, it may lead to hallucinations, restlessness, confusion, elevated heart rate and blood pressure, and psychosis.
Almost half of 9 and 10-year-olds get HPV vaccination at first opportunity This spring, more than 800,000 young people received an invitation to be vaccinated against HPV, the human papillomavirus.
Joint Action CHRODIS PLUS: RIVM’s contribution to strengthening Health Promotion Within the Joint Action for the prevention and treatment of chronic diseases CHRODIS PLUS, RIVM has developed a set of recommendations for intersectoral cooperation to strengthen health promotion a
Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.
Preparations for COVID-19 vaccinations now in progress RIVM is preparing for implementation of the coronavirus vaccinations. As soon as there is a safe and effective vaccine against the novel coronavirus, it will be quickly and carefully deployed to vaccinate the target groups.